Stay updated on Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record now indicates it is not actively enrolling participants and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study); the revision tag was updated to v3.6.0 and the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.4%
    Check dated 2026-06-14T04:48:54.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a minor maintenance update to the page.
    Difference
    0.1%
    Check dated 2026-06-07T00:19:22.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page received a minor version update (revision to a newer build). This appears to be software maintenance with no visible changes to the study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-05-16T09:24:22.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page’s footer version/release label was updated from v3.5.2 to v3.5.3, indicating a ClinicalTrials.gov site revision rather than any modification to the trial record.
    Difference
    0.1%
    Check dated 2026-04-24T22:44:00.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:13:11.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:42:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.